Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb

T. Veverka, P. Hok, P. Otruba, J. Zapletalová, B. Kukolová, Z. Tüdös, A. Krobot, P. Kaňovský, P. Hluštík,

. 2019 ; 10 (-) : 495. [pub] 20190509

Language English Country Switzerland

Document type Journal Article

Post-stroke spasticity (PSS) is effectively treated with intramuscular botulinum toxin type A (BoNT-A), although the clinical improvement is likely mediated by changes at the central nervous system level. Using functional magnetic resonance imaging (fMRI) of the brain, this study aims to confirm and locate BoNT-A-related changes during motor imagery with the impaired hand in severe PSS. Temporary alterations in primary and secondary sensorimotor representation of the impaired upper limb were expected. Thirty chronic stroke patients with upper limb PSS undergoing comprehensive treatment including physiotherapy and indicated for BoNT treatment were investigated. A change in PSS of the upper limb was assessed with the modified Ashworth scale (MAS). fMRI and clinical assessments were performed before (W0) and 4 weeks (W4) and 11 weeks (W11) after BoNT-A application. fMRI data were acquired using 1.5-Tesla scanners during imagery of finger-thumb opposition sequences with the impaired hand. At the group level, we separately modeled (1) average activation at each time point with the MAS score and age at W0 as covariates; and (2) within-subject effect of BoNT-A and the effect of time since W0 as independent variables. Comprehensive treatment of PSS with BoNT-A significantly decreased PSS of the upper limb with a maximal effect at W4. Task-related fMRI prior to treatment (W0) showed extensive activation of bilateral frontoparietal sensorimotor cortical areas, bilateral cerebellum, and contralesional basal ganglia and thalamus. After BoNT-A application (W4), the activation extent decreased globally, mostly in the bilateral parietal cortices and cerebellum, but returned close to baseline at W11. The intra-subject contrast revealed a significant BoNT-A effect, manifesting as a transient decrease in the activation of the ipsilesional intraparietal sulcus and superior parietal lobule. We demonstrate that BoNT-A treatment of PSS of the upper limb is associated with transient changes in the ipsilesional posterior parietal cortex, possibly resulting from temporarily altered sensorimotor upper limb representations.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028952
003      
CZ-PrNML
005      
20190819103926.0
007      
ta
008      
190813s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fneur.2019.00495 $2 doi
035    __
$a (PubMed)31143157
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Veverka, Tomáš $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
245    10
$a Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb / $c T. Veverka, P. Hok, P. Otruba, J. Zapletalová, B. Kukolová, Z. Tüdös, A. Krobot, P. Kaňovský, P. Hluštík,
520    9_
$a Post-stroke spasticity (PSS) is effectively treated with intramuscular botulinum toxin type A (BoNT-A), although the clinical improvement is likely mediated by changes at the central nervous system level. Using functional magnetic resonance imaging (fMRI) of the brain, this study aims to confirm and locate BoNT-A-related changes during motor imagery with the impaired hand in severe PSS. Temporary alterations in primary and secondary sensorimotor representation of the impaired upper limb were expected. Thirty chronic stroke patients with upper limb PSS undergoing comprehensive treatment including physiotherapy and indicated for BoNT treatment were investigated. A change in PSS of the upper limb was assessed with the modified Ashworth scale (MAS). fMRI and clinical assessments were performed before (W0) and 4 weeks (W4) and 11 weeks (W11) after BoNT-A application. fMRI data were acquired using 1.5-Tesla scanners during imagery of finger-thumb opposition sequences with the impaired hand. At the group level, we separately modeled (1) average activation at each time point with the MAS score and age at W0 as covariates; and (2) within-subject effect of BoNT-A and the effect of time since W0 as independent variables. Comprehensive treatment of PSS with BoNT-A significantly decreased PSS of the upper limb with a maximal effect at W4. Task-related fMRI prior to treatment (W0) showed extensive activation of bilateral frontoparietal sensorimotor cortical areas, bilateral cerebellum, and contralesional basal ganglia and thalamus. After BoNT-A application (W4), the activation extent decreased globally, mostly in the bilateral parietal cortices and cerebellum, but returned close to baseline at W11. The intra-subject contrast revealed a significant BoNT-A effect, manifesting as a transient decrease in the activation of the ipsilesional intraparietal sulcus and superior parietal lobule. We demonstrate that BoNT-A treatment of PSS of the upper limb is associated with transient changes in the ipsilesional posterior parietal cortex, possibly resulting from temporarily altered sensorimotor upper limb representations.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hok, Pavel $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
700    1_
$a Otruba, Pavel $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
700    1_
$a Zapletalová, Jana $u Department of Biophysics, Biometry and Statistics, Palacký University and University Hospital, Olomouc, Czechia.
700    1_
$a Kukolová, Barbora $u Rehabilitation Centre, Hrabyně, Czechia.
700    1_
$a Tüdös, Zbyněk $u Department of Radiology, Palacký University and University Hospital, Olomouc, Czechia.
700    1_
$a Krobot, Alois $u Department of Physiotherapy, Palacký University and University Hospital, Olomouc, Czechia.
700    1_
$a Kaňovský, Petr $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia.
700    1_
$a Hluštík, Petr $u Department of Neurology, Palacký University and University Hospital, Olomouc, Czechia. Department of Radiology, Palacký University and University Hospital, Olomouc, Czechia.
773    0_
$w MED00174552 $t Frontiers in neurology $x 1664-2295 $g Roč. 10, č. - (2019), s. 495
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31143157 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190819104200 $b ABA008
999    __
$a ind $b bmc $g 1434101 $s 1067412
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 10 $c - $d 495 $e 20190509 $i 1664-2295 $m Frontiers in neurology $n Front. neurol. $x MED00174552
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...